Learning disabilities

Groundbreaking Alzheimer's Disease Blood Test Subject of Upcoming Webinar

Retrieved on: 
Thursday, May 20, 2021
Cognitive disorders, Branches of biology, Learning disabilities, Psychiatric diagnosis, Abnormal psychology, Alzheimer's disease, Dementia, Neuroscience, Psychiatry

Diagnosing Alzheimer\'s Disease: A Groundbreaking New Blood Test is free and open to the public.

Key Points: 
  • Diagnosing Alzheimer\'s Disease: A Groundbreaking New Blood Test is free and open to the public.
  • Registration is required.\nCo-creator of first blood test to diagnose Alzheimer\'s to talk live about groundbreaking new test.\nDr.
  • Holtzman is a co-inventor of a new blood test, PrecivityAD, designed to assist physicians with diagnosing Alzheimer\'s disease.
  • Its funded initiatives have been responsible for several key breakthroughs including the groundbreaking "Alzheimer\'s in a Dish" study.

New study finds that Americans believe daylight is essential to their wellbeing, yet they spend most of their time indoors

Retrieved on: 
Thursday, May 20, 2021
Psychiatric diagnosis, Cognitive disorders, Branches of biology, Learning disabilities, Mind, Psychiatry, Abnormal psychology, Dementia, Alzheimer's disease, Sleep, Productivity

The study revealed that 83% of respondents agree that natural daylight is important for good health, affecting things such as sleep cycles, mental focus, and worker productivity.

Key Points: 
  • The study revealed that 83% of respondents agree that natural daylight is important for good health, affecting things such as sleep cycles, mental focus, and worker productivity.
  • Government studies put the numbers even higher, revealing that most Americans now spend 93% of their lives indoors[1].\nThe survey\'s findings around light\'s impact on sleep were particularly telling.
  • For the elderly, respondents believe light can improve symptoms of dementia and Alzheimer\'s, with more than 42% of respondents agreeing.
  • And two-thirds of adults (67%) believe natural light improves worker productivity.\nAll figures, unless otherwise stated, are from YouGov Plc.

GeneTx and Ultragenyx Receive Clearance from Health Canada to Begin Clinical Study of GTX-102 in Canada for the Treatment of Angelman Syndrome

Retrieved on: 
Wednesday, May 19, 2021
Branches of biology, Learning disabilities, Neurological disorders, Clinical medicine, Health, Genodermatoses, UBE3A, Angelman syndrome, Chromosome 15, Ube3a-ATS

Patients will then move to a maintenance phase during which they will receive GTX-102 every three months and continue to be monitored for response and safety.

Key Points: 
  • Patients will then move to a maintenance phase during which they will receive GTX-102 every three months and continue to be monitored for response and safety.
  • In almost all cases of Angelman syndrome, the maternal UBE3A allele is either missing or mutated, resulting in limited to no protein expression.
  • While individuals with Angelman syndrome have a normal lifespan, they require continuous care and are unable to live independently.
  • GeneTx was launched by FAST, a patient advocacy organization and the largest non-governmental funder of Angelman syndrome research.

Premier Game Table Brand, 11 Ravens, Announces New Limited Edition Wayne Gretzky (aka "The Great One") Stealth Table

Retrieved on: 
Tuesday, May 18, 2021
Food and drink, Cognitive disorders, Learning disabilities, Psychiatric diagnosis, Foods, Branches of biology, Dementia, Alzheimer's disease, Cake, Icing, Table

SAEF offers \'table tennis therapy\' to enhance the lives of individuals with Alzheimer\'s and other forms of dementia through specialized play.

Key Points: 
  • SAEF offers \'table tennis therapy\' to enhance the lives of individuals with Alzheimer\'s and other forms of dementia through specialized play.
  • The ice hockey legend customized the Stealth Table design to complement his home and stay active with his sports-oriented family.\n"Collaborations are a driving force for 11 Ravens.
  • "The fact that we are able to share the same passion for this game is icing on the cake.
  • "\n11 Ravens tables can be found in the most luxurious homes and hotels around the world.

Loyal Source Raises Over $160,000 for Central Florida Nonprofit During 14th Annual Derby Day Event

Retrieved on: 
Monday, May 17, 2021
Psychiatric diagnosis, Branches of biology, Abnormal psychology, Psychiatry, Autism, Learning disabilities, Neurological disorders, Pervasive developmental disorders, Autism spectrum

Despite hurdles from the ongoing pandemic, this is the largest donation to date stemming from this annual event.\nPALS\xe2\x80\x99s mission is to create opportunities for individuals of all ages with autism spectrum disorders (ASD) by providing state-of-the-art social inclusive community programs in Central Florida.

Key Points: 
  • Despite hurdles from the ongoing pandemic, this is the largest donation to date stemming from this annual event.\nPALS\xe2\x80\x99s mission is to create opportunities for individuals of all ages with autism spectrum disorders (ASD) by providing state-of-the-art social inclusive community programs in Central Florida.
  • \xe2\x80\x9cThis generous donation will go directly to support our work with individuals and families living with autism and related disorders throughout Central Florida.\xe2\x80\x9d\nLoyal Source is committed to supporting the Central Florida community through philanthropic initiatives.
  • With a focus in government healthcare, technical and support services, engineering, and travel healthcare, Loyal Source provides exceptional custom solutions to both private enterprise and government agencies.
  • For more information about Loyal Source, visit https://loyalsource.com/ .\n'

New Center for Children on the Autism Spectrum Opening in Elgin

Retrieved on: 
Friday, May 14, 2021
Psychiatric diagnosis, Autism, Branches of biology, Abnormal psychology, Psychiatry, Learning disabilities, Autism Speaks, Autism rights movement, Geraldine Dawson

b'ELGIN, Ill., May 14, 2021 /PRNewswire/ -- Caravel Autism Health is opening a new autism therapy center for children this spring.

Key Points: 
  • b'ELGIN, Ill., May 14, 2021 /PRNewswire/ -- Caravel Autism Health is opening a new autism therapy center for children this spring.
  • The new center at 2155 Point Boulevard in Elgin is designed to meet the unique needs of children with autism and their families.\nCaravel\'s Clinic Director Tiffany Spicer, BCBA, an autism specialist who grew up in Elgin and Bartlett, will oversee the new location.
  • The efficacy of ABA treatment for children with autism is recognized by Autism Speaks, the American Psychological Association, and the U.S.
  • Our team of clinical experts specializes in the evaluation, diagnosis, and treatment of children on the autism spectrum.

Headlands Research Continues its Rapid Expansion with the Acquisition of Summit Research Network and the Launch of its Fourth Horizons Site

Retrieved on: 
Thursday, May 13, 2021
Cognitive disorders, Learning disabilities, Psychiatric diagnosis, Psychiatry, Branches of biology, Cognition, Dementia, Alzheimer's disease, Research site

b'SAN FRANCISCO, May 13, 2021 (GLOBE NEWSWIRE) -- Headlands Research ( www.headlandsresearch.com ), a global next-generation clinical research site organization, today announced its acquisition of Summit Research Network in Portland, Oregon.

Key Points: 
  • b'SAN FRANCISCO, May 13, 2021 (GLOBE NEWSWIRE) -- Headlands Research ( www.headlandsresearch.com ), a global next-generation clinical research site organization, today announced its acquisition of Summit Research Network in Portland, Oregon.
  • The acquisition follows Headlands\xe2\x80\x99 recent addition of Artemis Institute for Clinical Research in February of this year.
  • Coupled with the new acquisition, Headlands Research also launched its fourth Horizons site in Scottsdale, AZ, which expands its global network to 15 clinical trial sites.\nSummit Research Network, founded in 1976, is dedicated to improving medical treatment by conducting high quality scientific research and patient care.
  • Summit Research Network specializes in the areas of psychiatry, dementia and other age-related memory conditions such as Alzheimer\xe2\x80\x99s and Lewy Bodies, and operates a specialized Memory Health Center ( www.memoryhealthcenter.com ).

Trial First to Show Improvements in Alzheimer's Patients

Retrieved on: 
Thursday, May 13, 2021
Cognitive disorders, Learning disabilities, Psychiatric diagnosis, Bredesen, Dementia, Toups, Psychiatry, Cognition

Kat Toups, Ann Hathaway, and Deborah Gordonalong with Dr. Dale Bredesen, a professor at UCLA.\nTheir proof-of-concept trial included 25 participants, aged 50 to 76, all with MCI (pre-Alzheimer\'s) or early-stage dementia.

Key Points: 
  • Kat Toups, Ann Hathaway, and Deborah Gordonalong with Dr. Dale Bredesen, a professor at UCLA.\nTheir proof-of-concept trial included 25 participants, aged 50 to 76, all with MCI (pre-Alzheimer\'s) or early-stage dementia.
  • The report concluded that a larger, randomized controlled trial is warranted, and this follow-up study is already in the works.
  • ; Henrianna Chung; Alan Boyd; Benjamin Hill, Ph.D.; Mouna Attarha, Ph.D.; Won Jong Chwa; Michael Jarrett, Ph.D; and Dale Bredesen, M.D.
  • This study was supported with funding by the Four Winds Foundation; performed in collaboration with QuesGen Systems, Inc. CRO.

Diadem Presents New Data at AAIC® Symposium Showing Its Blood-Based Biomarker Test Accurately Predicts Progression to Alzheimer's Disease 7 Years Before Symptoms Occur

Retrieved on: 
Thursday, May 13, 2021
Branches of biology, Biology, Biomarkers, Psychiatric diagnosis, Life sciences, Cognitive disorders, Learning disabilities, Dementia, Alzheimer's disease

The new study results are being presented today at the 2021 Alzheimer\'s Association International Conference (AAIC) Satellite Symposium .

Key Points: 
  • The new study results are being presented today at the 2021 Alzheimer\'s Association International Conference (AAIC) Satellite Symposium .
  • Additionally, the prognostic performance of the Diadem biomarker test was superior to covariate measures including age, gender, and APOE-related genetic susceptibility, either alone or in combination with amyloid status.
  • The company is developing the first blood-based prognostic test for the early detection of dementia, with a focus on Alzheimer\'s disease.
  • Diadem is preparing for rapid commercialization of its initial Alzheimer\'s prognostic via a global launch in collaboration with strategic partners.

New Report Describes Better Framework for Assessing the Value of Alzheimer's Therapies

Retrieved on: 
Wednesday, May 12, 2021
Health Economics, Health, Health care quality, Articles, Branches of biology, Cognitive disorders, Learning disabilities, Psychiatric diagnosis, Quality-adjusted life year, Alzheimer's disease

b'WASHINGTON, May 12, 2021 /PRNewswire/ --Today the Alliance for Aging Research released a report, " Assessing the Value of Therapies in Alzheimer\'s Disease: Considerations to create a practical approach to value ," which the Alliance had commissioned from Milliman .

Key Points: 
  • b'WASHINGTON, May 12, 2021 /PRNewswire/ --Today the Alliance for Aging Research released a report, " Assessing the Value of Therapies in Alzheimer\'s Disease: Considerations to create a practical approach to value ," which the Alliance had commissioned from Milliman .
  • The report outlines a new framework for assessing the value of Alzheimer\'s treatments and describes how the traditional approach to value assessment for therapeutics fails to address the challenges posed by Alzheimer\'s disease (AD) and suggests principles to create an alternative, equitable value assessment framework.
  • The report explores technical issues with the use of quality adjusted life years (QALYs) that render the traditional approach problematic.
  • The QALY has significant limitations when dealing with complex diseases such as AD, as they do not recognize value driven by public health improvement, transformation, or even societal value.